Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of “Hold” by Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been given an average rating of “Hold” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company.

Several equities research analysts have recently issued reports on RHHBY shares. Sanford C. Bernstein raised shares of Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Morgan Stanley started coverage on shares of Roche in a research report on Wednesday. They set an “equal weight” rating for the company.

Hedge Funds Weigh In On Roche

Institutional investors and hedge funds have recently modified their holdings of the company. Bard Financial Services Inc. raised its stake in Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the period. Diversified Trust Co raised its stake in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the period. Hantz Financial Services Inc. increased its position in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after acquiring an additional 305 shares in the last quarter. Brooklyn Investment Group increased its position in shares of Roche by 36.6% in the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after acquiring an additional 363 shares in the last quarter. Finally, Canopy Partners LLC increased its position in shares of Roche by 4.6% in the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after acquiring an additional 344 shares in the last quarter.

Roche Trading Down 0.6 %

Roche stock opened at $41.05 on Wednesday. Roche has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. The firm has a 50 day moving average price of $36.95 and a 200 day moving average price of $38.33.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.